Experimental Alzheimer’s disease drug hailed as a success

An experimental drug for Alzheimer’s disease has shown to slow down the rate of decline in memory and thinking in people with early stage of Alzheimer’s disease. This is being hailed as a “historic moment” for dementia treatment. The cognition level of Alzheimer’s patients who were given the drug, which has been developed by Eisai and Biogen, declined by 27 per cent less than the patients who were on a placebo treatment after a period of 18 months. This is a modest but very significant change in clinical outcome, first time a drug has been clearly shown to change the disease’s trajectory.

The study enrolled around 1,800 patients with early stage Alzheimer’s, and these patients were given twice-weekly infusions of the drug called lecanemab. The drug also showed to “reduce toxic plaques in the brain and slow patients’ memory decline and ability to perform day-to-day tasks”. About a fifth of enrolled patients experienced side effects that include brain swelling or brain bleeding which was visible on PET scans, with about 3 per cent of them experiencing symptomatic side effects.

Keep Reading

The results of this study provide boost to the “amyloid hypothesis”, that assumes that “sticky plaques seen in the brains of dementia patients play a role in damaging brain cells and causing cognitive decline”.

“This is a historic moment for dementia research, as this is the first phase 3 trial of an Alzheimer’s drug in a generation to successfully slow cognitive decline,” said Dr Susan Kohlhaas, the director of research at Alzheimer’s Research UK. “Many people feel Alzheimer’s is an inevitable part of ageing. This spells it out: if you intervene early you can make an impact on how people progress.”

Rob Howard, a professor of old age psychiatry at University College London (UCL), said, “This is an unambiguously statistically positive result and represents something of an historic moment when we see the first convincing modification of Alzheimer’s disease. God knows, we’ve waited long enough for this.”

EU Reporter

As vast is the European region, the more diverse are the developments and news that are to be known. I bring to table the news and political affairs from region to your screens.

Recent Posts

Mercosur and UAE Move Closer to Landmark Free Trade Agreement

Negotiation of the trade agreement with Mercosur and increasing interest in Middle Eastern market advances with the potential to drive… Read More

November 14, 2024

Top Grossing Local Film: “Hello, Love, Again” Earns ₱85M on First Day

"Hello, Love, Again," the movie starring Kapamilya actress Kathryn Bernardo and Alden Richards earned over ₱85 million on its first… Read More

November 14, 2024

Ex-Captain Rashid Latif Advocates Pakistan’s Cricket Independence from India

Former Pakistan cricketer Rashid Latif has voiced strong opinions about cricket match between India and Pakistan. He said that Pakistan… Read More

November 13, 2024

Slow Progress on Colombia’s Land Reform Efforts Stalls Hopes for Peace and Stability

President Gustavo Petro’s goal of redistributing land in Colombia—an issue central to the 2016 peace agreement between the government and… Read More

November 13, 2024

Fox News Host Pete Hegseth Nominated to Lead Pentagon Under Trump Administration

In a rather surprising decision, Donald Trump suggested Pete Hegseth, a news anchor at Fox News, become the Secretary of… Read More

November 13, 2024

Mike Tyson vs. Jake Paul Fight Rescheduled for November 15 in Texas

The fight between Mike Tyson and Jake Paul has been moved to November 15. This fight will take place at… Read More

November 13, 2024

This website uses cookies.

Read More